303 related articles for article (PubMed ID: 26482324)
1. Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children.
Brodlie M; Gupta A; Rodriguez-Martinez CE; Castro-Rodriguez JA; Ducharme FM; McKean MC
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD008202. PubMed ID: 26482324
[TBL] [Abstract][Full Text] [Related]
2. Leukotriene receptor antagonists for eczema.
Ferguson L; Futamura M; Vakirlis E; Kojima R; Sasaki H; Roberts A; Mori R
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011224. PubMed ID: 30343498
[TBL] [Abstract][Full Text] [Related]
3. Interventions for autumn exacerbations of asthma in children.
Pike KC; Akhbari M; Kneale D; Harris KM
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012393. PubMed ID: 29518252
[TBL] [Abstract][Full Text] [Related]
4. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
Chauhan BF; Ducharme FM
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003137. PubMed ID: 24459050
[TBL] [Abstract][Full Text] [Related]
5. Leukotriene inhibitors for bronchiolitis in infants and young children.
Liu F; Ouyang J; Sharma AN; Liu S; Yang B; Xiong W; Xu R
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010636. PubMed ID: 25773054
[TBL] [Abstract][Full Text] [Related]
6. Daily inhaled corticosteroids or montelukast for preschoolers with asthma or recurrent wheezing: A systematic review.
Castro-Rodriguez JA; Rodriguez-Martinez CE; Ducharme FM
Pediatr Pulmonol; 2018 Dec; 53(12):1670-1677. PubMed ID: 30394700
[TBL] [Abstract][Full Text] [Related]
7. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
[TBL] [Abstract][Full Text] [Related]
8. Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthma.
Chauhan BF; Ben Salah R; Ducharme FM
Cochrane Database Syst Rev; 2013 Oct; (10):CD009585. PubMed ID: 24089325
[TBL] [Abstract][Full Text] [Related]
9. Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial.
Nwokoro C; Pandya H; Turner S; Eldridge S; Griffiths CJ; Vulliamy T; Price D; Sanak M; Holloway JW; Brugha R; Koh L; Dickson I; Rutterford C; Grigg J
Lancet Respir Med; 2014 Oct; 2(10):796-803. PubMed ID: 25212745
[TBL] [Abstract][Full Text] [Related]
10. Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults.
Chong J; Haran C; Chauhan BF; Asher I
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD011032. PubMed ID: 26197430
[TBL] [Abstract][Full Text] [Related]
11. Inhaled steroids for episodic viral wheeze of childhood.
McKean M; Ducharme F
Cochrane Database Syst Rev; 2000; 2000(2):CD001107. PubMed ID: 10796596
[TBL] [Abstract][Full Text] [Related]
12. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ram FS; Cates CJ; Ducharme FM
Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
[TBL] [Abstract][Full Text] [Related]
13. Leukotriene receptor antagonists as maintenance or intermittent treatment in pre-school children with episodic viral wheeze.
Brodlie M; Gupta A; Rodriguez-Martinez CE; Castro-Rodriguez JA; Ducharme FM; McKean MC
Paediatr Respir Rev; 2016 Jan; 17():57-9. PubMed ID: 26628194
[No Abstract] [Full Text] [Related]
14. A meta-analysis of montelukast for recurrent wheeze in preschool children.
Hussein HR; Gupta A; Broughton S; Ruiz G; Brathwaite N; Bossley CJ
Eur J Pediatr; 2017 Jul; 176(7):963-969. PubMed ID: 28567533
[TBL] [Abstract][Full Text] [Related]
15. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2011 May; (5):CD003137. PubMed ID: 21563136
[TBL] [Abstract][Full Text] [Related]
16. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children.
Watts K; Chavasse RJ
Cochrane Database Syst Rev; 2012 May; 2012(5):CD006100. PubMed ID: 22592708
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory medications for obstructive sleep apnoea in children.
Kuhle S; Hoffmann DU; Mitra S; Urschitz MS
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD007074. PubMed ID: 31978261
[TBL] [Abstract][Full Text] [Related]
19. Addition of antileukotriene agents to inhaled corticosteroids in children with persistent asthma.
Chong JK; Chauhan BF
Paediatr Child Health; 2014 Nov; 19(9):473-4. PubMed ID: 25414582
[TBL] [Abstract][Full Text] [Related]
20. Symptomatic treatment of the cough in whooping cough.
Wang K; Bettiol S; Thompson MJ; Roberts NW; Perera R; Heneghan CJ; Harnden A
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD003257. PubMed ID: 25243777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
